EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival

DSpace Repository

EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival

Author: Faehling, M.; Eckert, R.; Kamp, T.; Kuom, S.; Griese, U.; Straeter, J.; Ott, G.; Spengler, W.
Tübinger Autor(en):
Spengler, Werner
Published in: Lung Cancer (2013), Bd. 80, H. 3, S. 306-312
Verlagsangabe: Elsevier Ireland Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.lungcan.2013.02.010
ISSN: 0169-5002
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)